An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

November 22, 2017

Study Completion Date

November 22, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986205

Single dose, 100 mg administered at Day 1 and at Day 15.

Trial Locations (1)

78744

PPD Austin Clinic, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY